WebC4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It … WebAsset Growth. -14.98%. Trailing 12-Months. The C4 Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and ...
C4 Therapeutics (CCCC) Stock Forecast, Price & News
WebMar 31, 2024 · Complete C4 Therapeutics Inc. stock information by Barron's. View real-time CCCC stock price and news, along with industry-best analysis. WebCCCC Stock 12 Months Forecast $22.11 (627.30% Upside) Based on 9 Wall Street analysts offering 12 month price targets for C4 Therapeutics in the last 3 months. The average price target is $22.11 with a high forecast of $84.00 and a low forecast of $5.00. The average price target represents a 627.30% change from the last price of $3.04. is a gpa of 3.00 good
C4 Therapeutics, Inc. (CCCC) Company Profile & Facts - Yahoo …
WebTicker: CCCC. C4 Therapeutics Inc $ 3.12-8.24 % (1W) $ 1W 1M 1Y 5Y. Disclosure. The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return ... WebApr 12, 2024 · A high-level overview of C4 Therapeutics, Inc. (CCCC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebC4 Therapeutics, Inc., is committed to bringing new, innovative therapies to patients by continuously researching novel ways to treat cancer and other diseases through targeted … is a governor elected or appointed